Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C48H78O20 |
| Molecular Weight | 975.1209 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 28 / 28 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O
InChI
InChIKey=BNMGUJRJUUDLHW-HCZMHFOYSA-N
InChI=1S/C48H78O20/c1-19-10-11-48(13-12-46(6)22(28(48)20(19)2)8-9-27-44(4)14-24(52)39(61)45(5,18-50)38(44)23(51)15-47(27,46)7)43(62)68-42-35(59)32(56)30(54)26(66-42)17-63-40-36(60)33(57)37(25(16-49)65-40)67-41-34(58)31(55)29(53)21(3)64-41/h8,19-21,23-42,49-61H,9-18H2,1-7H3/t19-,20+,21+,23-,24-,25-,26-,27-,28+,29+,30-,31-,32+,33-,34-,35-,36-,37-,38-,39+,40-,41+,42+,44-,45+,46-,47-,48+/m1/s1
| Molecular Formula | C48H78O20 |
| Molecular Weight | 975.1209 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 28 / 28 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Madecassoside is a triterpenoid compound found in Centella asiatica (Gotu kola), a medicinal herb used in traditional Chinese medicine (TCM), Ayurvedic medicine, and traditional African medicine. Madecassoside has a wide range of reported biological activities including, anti-inflammatory, wound healing, and anti-oxidant activities. It has been reported to suppress LPS-induced TNF-alpha production via inhibition of ERK, p38, and NF-kappaB activity. Madecassoside, a triterpenoid derivative isolated from Centella asiatica, exhibits anti-inflammatory and antioxidant activities. Madecassoside significantly reduced brain infarct area, resolved neurological deficit, and ameliorated neuronal apoptosis. It also significantly reduced the levels of malondialdehyde and nitric oxide, and augmented the antioxidant activity in rats subjected to cerebral I/R. Moreover, the levels of pro-inflammatory cytokines and NF-κB p65 significantly reduced after madecassoside treatment. Madecassoside is neuroprotective and may be useful in reducing the damage caused by stroke. Madecassoside has being shown to inhibits melanin synthesis by blocking ultraviolet-induced inflammation.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25106808 | https://www.ncbi.nlm.nih.gov/pubmed/23876367
Curator's Comment: Madecassoside demonstrated protective activity against cognitive impairment induced by D-galactose in mice.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3622 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21349323 |
539.04 µM [IC50] | ||
Target ID: CHEMBL340 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21349323 |
453.32 µM [IC50] | ||
Target ID: WP408 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22829481 |
|||
Target ID: CHEMBL230 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19135346 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27588048 |
Primary | Unknown Approved UseUnknown |
||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Madecassoside, a triterpenoid saponin isolated from Centella asiatica herbs, protects endothelial cells against oxidative stress. | 2012-10 |
|
| In vitro inhibitory effects of asiaticoside and madecassoside on human cytochrome P450. | 2011-06 |
|
| Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice. | 2009-06 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24278045
Mice: Oral
administration of madecassoside at doses of 6 mg/kg,
12 mg/kg and 24 mg/kg to mice facilitated wound closure
in a time-dependent manner and complete wound closure
took place on the 20th day in the group receiving 24 mg/kg
of madecassoside.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22829481
Madecassoside (10, 30, 100 umol/L) could reverse morphological changes, elevate cell viability, increase glutathione levels, and decrease lactate dehydrogenase and malondialdehyde levels caused by H(2)O(2) in a concentration-dependent manner.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:11:21 GMT 2025
by
admin
on
Mon Mar 31 20:11:21 GMT 2025
|
| Record UNII |
CQ2F5O6YIY
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
252-076-1
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY | |||
|
34540-22-2
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY | |||
|
100000151623
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY | |||
|
CQ2F5O6YIY
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY | |||
|
DTXSID40956057
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY | |||
|
DB15532
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY | |||
|
87855
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY | RxNorm | ||
|
CQ2F5O6YIY
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY | |||
|
24825675
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY | |||
|
SUB125894
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY | |||
|
66651
Created by
admin on Mon Mar 31 20:11:21 GMT 2025 , Edited by admin on Mon Mar 31 20:11:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Constituent of Centella asiatica aerial parts.
|